IMVT - Immunovant, Inc.

QQQ $ 479.76 $ 5.15 (1.08 %)

DIA $ 411.97 $ 4.35 (1.07 %)

SPY $ 562.00 $ 5.91 (1.06 %)

TLT $ 98.37 $ 0.64 (0.65 %)

GLD $ 231.99 $ 2.65 (1.16 %)

Previous Close

$ 32.42

Open

Bid

$ 32.33 x 236

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 19.50 - $ 45.58

Volume

504,724

Average Volume

Market Cap

4.75B

Beta (5Y Monthly)

$ 1.29

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2024	06-30-2024	10-Q
2	05-29-2024	03-31-2024	10-K
3	02-12-2024	12-31-2023	10-Q
4	11-09-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-22-2023	03-31-2023	10-K
7	02-03-2023	12-31-2022	10-Q
8	11-04-2022	09-30-2022	10-Q
9	08-05-2022	06-30-2022	10-Q
10	06-08-2022	03-31-2022	10-K
11	02-04-2022	12-31-2021	10-Q
12	11-05-2021	09-30-2021	10-Q
13	08-09-2021	06-30-2021	10-Q
14	06-01-2021	03-31-2021	10-K
15	02-16-2021	12-31-2020	10-Q
16	11-12-2020	09-30-2020	10-Q
17	08-12-2020	06-30-2020	10-Q
18	06-29-2020	03-31-2020	10-K
19	02-14-2020	12-31-2019	10-Q
20	11-13-2019	09-30-2019	10-Q
21	08-12-2019	06-30-2019	10-Q
22	06-12-2019	03-31-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

UBS Maintains Buy on Immunovant, Lowers Pr...
08/13/2024 14:42:38

UBS analyst Colin Bristow maintains Immunovant (NASDAQ:IMVT) with a Buy and lowers the price target from $42 to $41.

JP Morgan Maintains Overweight on Immunova...
08/08/2024 16:16:24

JP Morgan analyst Brian Cheng maintains Immunovant (NASDAQ:IMVT) with a Overweight and lowers the price target from $51 to $46.

Cantor Fitzgerald Reiterates Overweight on...
08/07/2024 18:00:12

Cantor Fitzgerald analyst Louise Chen reiterates Immunovant (NASDAQ:IMVT) with a Overweight.

Immunovant Q1 EPS $(0.60) Misses $(0.53) E...
08/06/2024 21:11:30

Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.53) ...

Cantor Fitzgerald Reiterates Overweight on...
06/20/2024 17:36:27

Cantor Fitzgerald analyst Louise Chen reiterates Immunovant (NASDAQ:IMVT) with a Overweight.

Cantor Fitzgerald Reiterates Overweight on...
06/18/2024 14:06:18

Cantor Fitzgerald analyst Louise Chen reiterates Immunovant (NASDAQ:IMVT) with a Overweight.

Oppenheimer Maintains Outperform on Immuno...
06/03/2024 12:26:25

Oppenheimer analyst Leland Gershell maintains Immunovant (NASDAQ:IMVT) with a Outperform and lowers the price target from $5...

Cantor Fitzgerald Reiterates Overweight on...
05/30/2024 15:47:36

Cantor Fitzgerald analyst Louise Chen reiterates Immunovant (NASDAQ:IMVT) with a Overweight.

HC Wainwright & Co. Reiterates Buy on Immu...
05/30/2024 11:25:01

HC Wainwright & Co. analyst Douglas Tsao reiterates Immunovant (NASDAQ:IMVT) with a Buy and maintains $51 price target.

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
05/29/2024 20:31:09

Immunovant Q4 EPS $(0.52) Misses $(0.43) E...
05/29/2024 20:05:36

Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.43) ...

biohaven-stock-stumbles-as-protein-degrading-drug-falls-short-of-expectations-in-early-stage-study

Biohaven Stock Stumbles As Protein-Degradi...
05/29/2024 18:47:15

Biohaven shares drop as interim data from the Phase 1 study of BHV-1300 fell short of investor expectations.

why-bank-of-montreal-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Bank of Montreal Shares Are Trading Lo...
05/29/2024 17:28:35

heico-posts-upbeat-earnings-joins-surmodics-abercrombie--fitch-and-other-big-stocks-moving-higher-on-wednesday

Heico Posts Upbeat Earnings, Joins Surmodi...
05/29/2024 14:38:24

Oppenheimer Initiates Coverage On Immunova...
03/28/2024 10:49:49

Oppenheimer analyst Leland Gershell initiates coverage on Immunovant (NASDAQ:IMVT) with a Outperform rating and announces Pr...

Truist Securities Reiterates Buy on Immuno...
03/25/2024 16:11:34

Truist Securities analyst Robyn Karnauskas reiterates Immunovant (NASDAQ:IMVT) with a Buy and maintains $48 price target.

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
03/21/2024 13:05:49

Goldman Sachs Initiates Coverage On Immuno...
03/13/2024 12:38:42

Goldman Sachs analyst Corinne Johnson initiates coverage on Immunovant (NASDAQ:IMVT) with a Buy rating and announces Price T...

Immunovant Awarded U.S. Patent for IMVT-1402
03/12/2024 11:32:37

Wolfe Research Initiates Coverage On Immun...
02/15/2024 11:40:04

Wolfe Research analyst Andy Chen initiates coverage on Immunovant (NASDAQ:IMVT) with a Outperform rating and announces Price...